Company profile
Ridgeline Therapeutics company profile
Ridgeline Therapeutics is emerging biotechnology developing new drugs to cure Type 2 diabetes, muscular, age-related muscle degeneration.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2017-01-01, Year
Headquarters
- Headquarters
- Awendaw, South Carolina, United States
- Postal code
- 77005
- Country code
- US
- Continent
- North America